Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss of $0.14/Share

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 EPS of ($0.14), versus ($0.18) reported last year.

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• Applied Materials surges as CEO signals multi-year chip boom
• SEI Investments (SEIC) PT Raised to $115 at Morgan Stanley